209 related articles for article (PubMed ID: 34810225)
1. Mouse Homologue of Human HLA-DO Does Not Preempt Autoimmunity but Controls Murine Gammaherpesvirus MHV68.
Lee J; Cullum E; Stoltz K; Bachmann N; Strong Z; Millick DD; Denzin LK; Chang A; Tarakanova V; Chervonsky AV; Golovkina T
J Immunol; 2021 Dec; 207(12):2944-2951. PubMed ID: 34810225
[TBL] [Abstract][Full Text] [Related]
2. The role of H2-O and HLA-DO in major histocompatibility complex class II-restricted antigen processing and presentation.
Alfonso C; Liljedahl M; Winqvist O; Surh CD; Peterson PA; Fung-Leung WP; Karlsson L
Immunol Rev; 1999 Dec; 172():255-66. PubMed ID: 10631951
[TBL] [Abstract][Full Text] [Related]
3. HLA-DO Modulates the Diversity of the MHC-II Self-peptidome.
Nanaware PP; Jurewicz MM; Leszyk JD; Shaffer SA; Stern LJ
Mol Cell Proteomics; 2019 Mar; 18(3):490-503. PubMed ID: 30573663
[TBL] [Abstract][Full Text] [Related]
4. Revisiting nonclassical HLA II functions in antigen presentation: Peptide editing and its modulation.
Álvaro-Benito M; Freund C
HLA; 2020 Oct; 96(4):415-429. PubMed ID: 32767512
[TBL] [Abstract][Full Text] [Related]
5. H2-M, a facilitator of MHC class II peptide loading, and its negative modulator H2-O are differentially expressed in response to proinflammatory cytokines.
Walter W; Scheuer C; Lingnau K; Reichert TE; Schmitt E; Loos M; Maeurer MJ
Immunogenetics; 2000 Aug; 51(10):794-804. PubMed ID: 10970094
[TBL] [Abstract][Full Text] [Related]
6. Targeted regulation of self-peptide presentation prevents type I diabetes in mice without disrupting general immunocompetence.
Yi W; Seth NP; Martillotti T; Wucherpfennig KW; Sant'Angelo DB; Denzin LK
J Clin Invest; 2010 Apr; 120(4):1324-36. PubMed ID: 20200448
[TBL] [Abstract][Full Text] [Related]
7. Biological function of HLA-DO (H2-O).
Chen X; Jensen PE
Crit Rev Immunol; 2014; 34(3):215-25. PubMed ID: 24941074
[TBL] [Abstract][Full Text] [Related]
8. HLA-DO increases bacterial superantigen binding to human MHC molecules by inhibiting dissociation of class II-associated invariant chain peptides.
Pezeshki AM; Azar GA; Mourad W; Routy JP; Boulassel MR; Denzin LK; Thibodeau J
Hum Immunol; 2013 Oct; 74(10):1280-7. PubMed ID: 23756162
[TBL] [Abstract][Full Text] [Related]
9. HLA-DM catalytically enhances peptide dissociation by sensing peptide-MHC class II interactions throughout the peptide-binding cleft.
Reyes-Vargas E; Barker AP; Zhou Z; He X; Jensen PE
J Biol Chem; 2020 Mar; 295(10):2959-2973. PubMed ID: 31969393
[TBL] [Abstract][Full Text] [Related]
10. H2-Mbeta 1 and H2-Mbeta 2 heterodimers equally promote clip removal in I-A(q) molecules from autoimmune-prone DBA/1 mice.
Walter W; Scheuer C; Loos M; Reichert TE; Maeurer MJ
J Biol Chem; 2001 Apr; 276(14):11086-91. PubMed ID: 11148202
[TBL] [Abstract][Full Text] [Related]
11. The mechanism of HLA-DM induced peptide exchange in the MHC class II antigen presentation pathway.
Schulze MS; Wucherpfennig KW
Curr Opin Immunol; 2012 Feb; 24(1):105-11. PubMed ID: 22138314
[TBL] [Abstract][Full Text] [Related]
12. Peptide linkage to the α-subunit of MHCII creates a stably inverted antigen presentation complex.
Schlundt A; Günther S; Sticht J; Wieczorek M; Roske Y; Heinemann U; Freund C
J Mol Biol; 2012 Oct; 423(3):294-302. PubMed ID: 22820093
[TBL] [Abstract][Full Text] [Related]
13. H2-O, a MHC class II-like protein, sets a threshold for B-cell entry into germinal centers.
Draghi NA; Denzin LK
Proc Natl Acad Sci U S A; 2010 Sep; 107(38):16607-12. PubMed ID: 20807742
[TBL] [Abstract][Full Text] [Related]
14. Altered major histocompatibility complex class II peptide loading in H2-O-deficient mice.
Perraudeau M; Taylor PR; Stauss HJ; Lindstedt R; Bygrave AE; Pappin DJ; Ellmerich S; Whitten A; Rahman D; Canas B; Walport MJ; Botto M; Altmann DM
Eur J Immunol; 2000 Oct; 30(10):2871-80. PubMed ID: 11069069
[TBL] [Abstract][Full Text] [Related]
15. Human Hepatitis B Viral Infection Outcomes Are Linked to Naturally Occurring Variants of
Graves AM; Virdis F; Morrison E; Álvaro-Benito M; Khan AA; Freund C; Golovkina TV; Denzin LK
J Immunol; 2020 Aug; 205(4):923-935. PubMed ID: 32690655
[TBL] [Abstract][Full Text] [Related]
16. Peptidomic analysis of type 1 diabetes associated HLA-DQ molecules and the impact of HLA-DM on peptide repertoire editing.
Zhou Z; Reyes-Vargas E; Escobar H; Chang KY; Barker AP; Rockwood AL; Delgado JC; He X; Jensen PE
Eur J Immunol; 2017 Feb; 47(2):314-326. PubMed ID: 27861808
[TBL] [Abstract][Full Text] [Related]
17. MHC class II antigen presentation pathway in murine tumours: tumour evasion from immunosurveillance?
Walter W; Lingnau K; Schmitt E; Loos M; Maeurer MJ
Br J Cancer; 2000 Nov; 83(9):1192-201. PubMed ID: 11027433
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of HLA-DM Mediated MHC Class II Peptide Loading by HLA-DO Promotes Self Tolerance.
Denzin LK
Front Immunol; 2013 Dec; 4():465. PubMed ID: 24381574
[TBL] [Abstract][Full Text] [Related]
19. HLA-DMA polymorphisms differentially affect MHC class II peptide loading.
Álvaro-Benito M; Wieczorek M; Sticht J; Kipar C; Freund C
J Immunol; 2015 Jan; 194(2):803-16. PubMed ID: 25505276
[TBL] [Abstract][Full Text] [Related]
20. Altered antigen presentation in mice lacking H2-O.
Liljedahl M; Winqvist O; Surh CD; Wong P; Ngo K; Teyton L; Peterson PA; Brunmark A; Rudensky AY; Fung-Leung WP; Karlsson L
Immunity; 1998 Feb; 8(2):233-43. PubMed ID: 9492004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
